HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 87 filers reported holding HARVARD BIOSCIENCE INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $104,706 | +1208.8% | 37,800 | +3189.8% | 0.00% | – |
Q1 2021 | $8,000 | -68.0% | 1,149 | -80.8% | 0.00% | – |
Q4 2020 | $25,000 | +316.7% | 5,988 | +236.6% | 0.00% | – |
Q3 2020 | $6,000 | -45.5% | 1,779 | -41.9% | 0.00% | – |
Q2 2020 | $11,000 | – | 3,061 | +5786.5% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 52 | -99.8% | 0.00% | – |
Q1 2019 | $96,000 | +33.3% | 22,163 | -2.3% | 0.00% | – |
Q4 2018 | $72,000 | -38.5% | 22,678 | +1.2% | 0.00% | – |
Q3 2018 | $117,000 | -1.7% | 22,409 | -0.0% | 0.00% | – |
Q2 2018 | $119,000 | +8.2% | 22,412 | +1.1% | 0.00% | – |
Q1 2018 | $110,000 | -89.7% | 22,162 | -92.1% | 0.00% | -100.0% |
Q3 2015 | $1,065,000 | -71.8% | 281,878 | -57.4% | 0.00% | -75.0% |
Q2 2015 | $3,771,000 | -9.0% | 661,513 | -7.1% | 0.00% | -20.0% |
Q1 2015 | $4,144,000 | -28.1% | 711,988 | -30.0% | 0.01% | -28.6% |
Q4 2014 | $5,764,000 | +40.7% | 1,016,628 | +1.5% | 0.01% | +40.0% |
Q3 2014 | $4,097,000 | +9.0% | 1,001,830 | +21.3% | 0.01% | +25.0% |
Q2 2014 | $3,757,000 | – | 825,668 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Engine Capital Management, LP | 3,542,852 | $10,536,000 | 4.92% |
Fondren Management LP | 865,000 | $2,660,000 | 2.21% |
Harvey Partners, LLC | 742,500 | $2,283,000 | 1.65% |
BARD ASSOCIATES INC | 311,922 | $959,000 | 0.49% |
Adirondack Research & Management Inc. | 131,042 | $403,000 | 0.35% |
Granahan Investment Management | 1,771,964 | $5,449,000 | 0.30% |
DALTON GREINER HARTMAN MAHER & CO | 1,373,518 | $4,224,000 | 0.29% |
HEARTLAND ADVISORS INC | 1,000,000 | $3,075,000 | 0.24% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 499,616 | $1,536,000 | 0.22% |
Alambic Investment Management, L.P. | 43,569 | $134,000 | 0.10% |